MX9100072A - Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales - Google Patents

Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales

Info

Publication number
MX9100072A
MX9100072A MX9100072A MX9100072A MX9100072A MX 9100072 A MX9100072 A MX 9100072A MX 9100072 A MX9100072 A MX 9100072A MX 9100072 A MX9100072 A MX 9100072A MX 9100072 A MX9100072 A MX 9100072A
Authority
MX
Mexico
Prior art keywords
methods
pharmaceutical compositions
inflammatory drugs
steroid anti
relieve symptoms
Prior art date
Application number
MX9100072A
Other languages
English (en)
Inventor
William J Goldman
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MX9100072A publication Critical patent/MX9100072A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
MX9100072A 1990-07-03 1991-07-03 Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales MX9100072A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54766290A 1990-07-03 1990-07-03

Publications (1)

Publication Number Publication Date
MX9100072A true MX9100072A (es) 1992-06-05

Family

ID=24185602

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100072A MX9100072A (es) 1990-07-03 1991-07-03 Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales

Country Status (7)

Country Link
EP (1) EP0465234A1 (es)
JP (1) JPH04230329A (es)
KR (1) KR920002149A (es)
AU (1) AU656140B2 (es)
CA (1) CA2046079A1 (es)
GT (1) GT199100052A (es)
MX (1) MX9100072A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
WO1993000895A1 (en) * 1991-07-04 1993-01-21 Taisho Pharmaceutical Co., Ltd. Analgesic
IN187379B (es) * 1996-04-12 2002-04-13 Panacea Biotec Ltd
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
JP2003095934A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
MX2010012479A (es) * 2010-11-16 2012-05-16 Posi Visionary Solutions Llp Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion.
KR20160004288A (ko) * 2013-05-06 2016-01-12 가오슝 창 궁 메모리얼 하스피털 약학적 조성물 및 이의 용도
KR101598283B1 (ko) * 2014-06-30 2016-02-29 이화여자대학교 산학협력단 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1139221A (en) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Antacid compositions
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament

Also Published As

Publication number Publication date
EP0465234A1 (en) 1992-01-08
KR920002149A (ko) 1992-02-28
GT199100052A (es) 1993-01-05
AU656140B2 (en) 1995-01-27
AU8014091A (en) 1992-01-09
JPH04230329A (ja) 1992-08-19
CA2046079A1 (en) 1992-01-04

Similar Documents

Publication Publication Date Title
BR9709267A (pt) Preparação de anticorpo monoclonal para administração a um humano formulação farmacêutica uso de uma preparação de anticorpo monoclonal e processo para a fabricação de uma preparação de anticorpo monoclonal
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
BR9608956A (pt) Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto
DE69205687T2 (de) Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum.
MX9100080A (es) Composiciones farmaceuticas y metodos para aliviar sintomas gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
BR9606604A (pt) Composto e método para a fabricação de um medicamento ou para aperfeiçoar o transporte de uma droga ou outro ativo para cruzar as membranas lipidicas no corpo ou assegurar a ação
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
MX9206953A (es) Composiciones fisiologicas de lagrima y metodos para su preparacion
DE68910892D1 (de) Arzneimittel zur Verhütung von sexuell übertragbaren Krankheiten.
MX9100072A (es) Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
ITRM920270A1 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
HUP0003546A3 (en) Compositions for administering taxanes orally to human patients
MX9100856A (es) Rotogranulaciones y revestimientos enmascarantes de sabor para la preparacion de tabletas farmaceuticas masticables
BR9506235A (pt) Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
BR9706938A (pt) Composto uso do mesmo formulação farmacêutica e processos para produzir o composto e para o tratamento ou a prevenção de sintomas ou efeitos de uma infecção virótica em um mamífero infectado incluindo um humano
ID21369A (id) Komposisi farmasi untuk penyembuhan penyakit yang disebabkan oleh virus
DE69726071D1 (de) Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
ITRM950544A0 (it) Uso della l-carnitina di suoi derivati e di loro sali farmaceuticamen-te accettabili in combinazione con farmaci antiretrovirali per ridurrei livelli di ceramide e potenziare l'attivita' di tali farmaci antire-trovirali per il trattamento terapeutico dell'invenzione...
MX9205454A (es) Composicion farmaceutica para administracion oral al tracto gastrointestinal que comprende calcitonina
BR9501832A (pt) Forma de dosagem farmaceutica capaz de ser engolida sólida para alivio temporário de tosses e inflamação da garganta
PT84996A (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
DE69026295T2 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten